Rare diseases
Investigational molecules
Locations
Back to the Netherlands1 940 clinical trials in Hoofddorp, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study on Maximizing Methotrexate Therapy for Patients with Active Rheumatoid Arthritis
The NetherlandsStudy of NVL-520 for Patients with Advanced ROS1-Positive Lung Cancer and Other Solid Tumors
The NetherlandsStudy on FOLFIRINOX, Pembrolizumab, and SABR for Patients with Borderline Resectable Pancreatic Cancer
The NetherlandsStudy of INBRX-109 with Irinotecan Hydrochloride Trihydrate and Temozolomide for Patients with Advanced Solid Tumors, Including Sarcomas
The NetherlandsStudy Comparing Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone with Ciltacabtagene Autoleucel or Stem Cell Transplant for Newly Diagnosed Multiple Myeloma Patients
The NetherlandsStudy of LB-100 and Atezolizumab for Patients with Metastatic Colorectal Cancer
The NetherlandsStudy of Patritumab Deruxtecan for Patients with Advanced or Metastatic Solid Tumors
The NetherlandsStudy Comparing Elranatamab to Drug Combinations for Patients with Relapsed/Refractory Multiple Myeloma After Anti-CD38 Therapy
The NetherlandsStudy on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis
The NetherlandsStudy on Adjusting Chemotherapy with Carboplatin and Paclitaxel for Patients with Poor Prognostic Ovarian Cancer
The NetherlandsStudy on Esmolol Hydrochloride, Dobutamine, and Milrinone for Patients with Cardiogenic Shock on V-A ECMO Support
The NetherlandsStudy on Preventing Heart Problems in Patients with Diffuse Large B-Cell Lymphoma Using Dexrazoxane and a Drug Combination
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on various cancer types including breast cancer, bladder cancer, and melanoma. Studies are evaluating novel treatment combinations and maintenance therapies for improved patient outcomes.
Multiple trials are investigating innovative approaches for both solid tumors and blood cancers, with particular emphasis on targeted therapies.
Comprehensive studies examining treatments for various blood disorders, including chronic myeloid leukemia, myelofibrosis, and lymphomas. Focus on developing targeted therapies and combination treatments.
Research aims to improve treatment outcomes and quality of life for patients with blood disorders.
Research initiatives addressing obesity management and surgical conditions like appendicitis. Studies include weight management therapies and surgical technique improvements.
Trials focus on both therapeutic and surgical interventions for better patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
